SEC Form 4 · accession 0000899243-19-000293
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Elsbree
Director
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2019 | M | 9,708 | — | A | 77,708 | D | |
| Common StockF2 | holding | — | — | — | 10,000 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Jan 1, 2019 | A | 13,289 | A | — | — | Common Stock | 13,289 | 13,289 | D |
| Restricted Stock UnitsF1,F4 | — | Jan 1, 2019 | M | 9,708 | A | — | — | Common Stock | 9,708 | 9,708 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F2The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- F3The restricted stock units were granted in accordance with the Issuer's Non-Employee Director Compensation Plan and vest on January 1, 2020.
- F4On January 1, 2018 the reporting person was granted 9,708 restricted stock units that vested on January 1, 2019.